Clinical trials of america winston salem nc

Founded in…. Richard L. The company is a dedicated research facility for all phases of pharmaceutical…. From Business: LabCorp, a leading global life sciences company, is deeply integrated in guiding patient care through comprehensive clinical laboratory services.

Advertise with Us. Solstas Lab Partners Medical Labs. LabCorp Medical Labs. Learn more. The purpose of this study is to evaluate the clinical and virologic benefit of pimodivir in combination with Standard-of-Care SOC treatment compared to placebo in combination with SOC treatment. Clinical Trials of America Change. Clinical Trials of America. DelRicht Research.

OLV Ziekenhuis. Centre Hospitalier d'Agen. Active not recruiting Agen cedex 9, FRA Hospital Cardiologica Aguascalientes. Civil Hospital. Cardiology Clinical Research. Active not recruiting Alberton, ZAF Hacettepe University Medical Faculty. Active not recruiting Ankara, TUR Korea University Ansan Hospital. Active not recruiting Ansan-si, The study will be conducted in 3 phases: screening phase, double-blind treatment period 5 days , a post treatment follow-up period 23 days.

The duration of participation in the study for each participant is 28 days. Participants will receive placebo matching to pimodivir, orally twice daily for 5 days on Days 1 through 5; for participants who will receive only 1 dose of placebo on Day 1 [evening], dosing will continue until the morning of Day 6.

Participants will receive pimodivir mg, orally, twice daily, for 5 days on Days 1 through 5; for participants who will receive only 1 dose of pimodivir on Day 1 [evening], dosing will continue until the morning of Day 6. Participants may receive SOC treatment as a part of background therapy. The choice to use influenza antivirals as part of the SOC should be made before randomization. The influenza antiviral should be started no later than Day 2 morning up to noon. Outcome measures are the tests that investigators perform to prove whether or not a treatment being tested in a clinical trial is having any effect.

The Flu-iiQ is a PRO that measures influenza symptom intensity none, mild, moderate, or severe on a 4 point Likert response rating scale ranging from 0 to 3, where "0" represents the absence of symptom and "3" represents the severe symptom. The resolution of influenza-related symptoms is defined as the beginning of the hour period that 7 influenza symptoms cough, sore throat, headache, nasal congestion, feeling feverish, body aches and pains, fatigue are at most mild or at least back to previous level of symptom severity in case the participant reported the symptom as pre-existing.

Time to influenza viral negativity will be determined by quantitative real time - polymerase chain reaction qRT-PCR and viral culture from nasal midturbinate MT swabs. The resolution of each influenza-related symptom is defined as the beginning of the hour period when the influenza symptom score is at most mild or at least back to previous level of symptom severity in case the participant reported the symptom as pre-existing. Learn More. The world's largest event to raise awareness and funds for Alzheimer's care, support and research.

Held 19 NC locations. Families facing Alzheimer's and all other dementia need us now more than ever. Register Today. Find help and resources. Find upcoming events, education opportunities, support groups and more. Browse articles and news releases.

Every dollar donated benefits those affected by Alzheimer's disease in your community. Learn about the Western Carolina Chapter. Advocating on behalf of those impacted by Alzheimer's disease and dementia in our area.